Pathology Visions (PV) 2023 Conference

Pathology Visions (PV) 2023 Conference organized by the Digital Pathology Association (DPA) will be held from Oct 29 - 31, 2023 at Hyatt Regency Orlando, Orlando, Florida, United States of America

Description:
Pathology Visions (PathVisions) is an innovative and informative conference that brings together experts across the field of digital pathology. PathVisions addresses the real-world, practical applications of digital pathology today, as well as the future of the field through new technologies and developments. If you are a clinician, researcher, technician, or trainee, PathVisions is the place for you. Be on the cutting edge with PathVisions.

Why Attend PATHVISIONS23?
Pathology Visions delivers education and best practice purveyance while influencing industry standards and contributing to the advancement of patient care. Attendees have access to expert presenters, thought leaders, pioneers in digital pathology, the latest product solutions and much more. Presentations cover a wide variety of digital pathology and AI applications.

Conference Objectives:

• Understand the basics of artificial intelligence and digital imaging
• Appreciate the importance of AI for digital pathology practice
• Recognize what digital pathology is and how it can be used in the practice of pathology
• Identify the barriers, risks, and challenges to implementing digital pathology
• Discuss current applications of digital pathology for research, education and clinical uses
• Describe the impact of digital pathology on standard pathology practice workflow
• Discuss the various analytic algorithms that can be applied to digital pathology and how they are best implemented
• Defend the important niche applications of digital pathology and how they might be applicable to individual practice settings
• Demonstrate how to evaluate digital slide scanners and supporting software in order to maximize your investment
• Identify the key drivers to the adoption of whole slide imaging
• State the challenges associated with interfacing a digital pathology system with an anatomic pathology information system
• Understand the current regulatory environment, particularly the FDA’s rulings concerning the use of digital pathology for primary diagnosis